492 results on '"Helin, Kristian"'
Search Results
2. Keep quiet: the HUSH complex in transcriptional silencing and disease
3. TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers
4. Vitamin C activates young LINE-1 elements in mouse embryonic stem cells via H3K9me3 demethylation
5. Author Correction: EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
6. H3K4me3 regulates RNA polymerase II promoter-proximal pause-release
7. The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes
8. EZH2i unlocks PDAC immune surveillance
9. Chromatin regulation of transcriptional enhancers and cell fate by the Sotos syndrome gene NSD1
10. The methylation inhibitor 3DZNep promotes HDR pathway choice during CRISPR-Cas9 genome editing
11. Author Correction: H3K4me3 regulates RNA polymerase II promoter-proximal pause-release
12. Histone editing elucidates the functional roles of H3K27 methylation and acetylation in mammals
13. BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation
14. CpG island reconfiguration for the establishment and synchronization of polycomb functions upon exit from naive pluripotency
15. Catching active enhancers via H2B N-terminal acetylation
16. Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia
17. RIO-kinase 2 is essential for hematopoiesis
18. Publisher Correction: H3K4me3 regulates RNA polymerase II promoter-proximal pause-release
19. RIO-kinase 2 is essential for hematopoiesis
20. Correction: Utx Is Required for Proper Induction of Ectoderm and Mesoderm during Differentiation of Embryonic Stem Cells.
21. TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis
22. MPP8 is essential for sustaining self-renewal of ground-state pluripotent stem cells
23. KDM4A regulates the maternal-to-zygotic transition by protecting broad H3K4me3 domains from H3K9me3 invasion in oocytes
24. ChIP-Sequencing of TET Proteins
25. An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions
26. Discovery of NSD2‐Degraders from Novel and Selective DEL Hits
27. Discovery of NSD2‐Degraders from Novel and Selective DEL Hits
28. Corrigendum: The Polycomb group proteins bind throughout theINK4A-ARFlocus and are disassociated in senescent cells
29. PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia
30. HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases
31. Vitamin C activates young LINE-1 elements in mouse embryonic stem cells via H3K9me3 demethylation
32. Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary
33. Accurate H3K27 methylation can be established de novo by SUZ12-directed PRC2
34. Figures S1-S5 from The SETDB1–TRIM28 Complex Suppresses Antitumor Immunity
35. Table S1 from The SETDB1–TRIM28 Complex Suppresses Antitumor Immunity
36. Data from The SETDB1–TRIM28 Complex Suppresses Antitumor Immunity
37. Data from PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2V617F-Mutant MPN
38. Supplementary Data from PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2V617F-Mutant MPN
39. Supplementary Table 1 from The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation
40. Supplementary Table 3 from The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation
41. Supplementary Table 2 from The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation
42. Supplementary Figure 5 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
43. Supplementary Figure 4 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
44. Supplementary Table 1 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
45. Supplementary Data from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
46. Supplementary Data from The Histone Methyltransferase and Putative Oncoprotein MMSET Is Overexpressed in a Large Variety of Human Tumors
47. Data from The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation
48. Figure S4 from The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation
49. Supplementary Table 4 from The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation
50. Supplementary Table 2 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.